Healthcare provider profile · identity verified

David Mark Cody, MD

Family Practice · CONCORD, NC · NPI 1952432817

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	419	106
Atorvastatin Calcium	Atorvastatin Calcium	419	106
Levothyroxine Sodium	Levothyroxine Sodium	289	70
Lisinopril	Lisinopril	282	78
Omeprazole	Omeprazole	268	77
Gabapentin	Gabapentin	220	59
Losartan Potassium	Losartan Potassium	208	63
Simvastatin	Simvastatin	203	54
Hydrochlorothiazide	Hydrochlorothiazide	169	50
Metformin Hcl	Metformin Hcl	160	42
Pravastatin Sodium	Pravastatin Sodium	141	37
Metoprolol Succinate	Metoprolol Succinate	138	38
Rosuvastatin Calcium	Rosuvastatin Calcium	138	37
Trazodone Hcl	Trazodone Hcl	138	32
Tramadol Hcl	Tramadol Hcl	113	38
Sertraline Hcl	Sertraline Hcl	112	27
Tamsulosin Hcl	Tamsulosin Hcl	103	27
Tizanidine Hcl	Tizanidine Hcl	99	37
Fluticasone Propionate	Fluticasone Propionate	98	37
Furosemide	Furosemide	97	23
Carvedilol	Carvedilol	96	24
Diclofenac Sodium	Diclofenac Sodium	94	38
Albuterol Sulfate Hfa	Albuterol Sulfate	92	22
Duloxetine Hcl	Duloxetine Hcl	88	20
Potassium Chloride	Potassium Chloride	88	22
Pantoprazole Sodium	Pantoprazole Sodium	85	23
Glipizide Er	Glipizide	84	21
Escitalopram Oxalate	Escitalopram Oxalate	83	20
Metoprolol Tartrate	Metoprolol Tartrate	82	24
Prednisone	Prednisone	81	65
Eliquis	Apixaban	77	13
Esomeprazole Magnesium	Esomeprazole Magnesium	77	13
Celecoxib	Celecoxib	76	26
Famotidine	Famotidine	69	22
Meloxicam	Meloxicam	67	24
Atenolol	Atenolol	66	17
Zolpidem Tartrate	Zolpidem Tartrate	64	23
Montelukast Sodium	Montelukast Sodium	63	22
Ozempic	Semaglutide	63	16
Allopurinol	Allopurinol	62	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	14
Clonazepam	Clonazepam	58	17
Doxycycline Monohydrate	Doxycycline Monohydrate	57	48
Ezetimibe	Ezetimibe	57	17
Hydralazine Hcl	Hydralazine Hcl	50	suppressed
Lorazepam	Lorazepam	50	11
Triamcinolone Acetonide	Triamcinolone Acetonide	49	22
Metformin Hcl Er	Metformin Hcl	48	15
Lovastatin	Lovastatin	47	12
Azelastine Hcl	Azelastine Hcl	46	20
Jardiance	Empagliflozin	46	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	20
Pregabalin	Pregabalin	45	15
Alprazolam	Alprazolam	42	12
Clopidogrel	Clopidogrel Bisulfate	42	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	42	11
Mupirocin	Mupirocin	39	35
Bupropion Xl	Bupropion Hcl	37	suppressed
Colchicine	Colchicine	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Sucralfate	Sucralfate	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	12
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Glipizide	Glipizide	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	27
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	24
Meclizine Hcl	Meclizine Hcl	27	16
Spironolactone	Spironolactone	27	suppressed
Primidone	Primidone	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	11
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	13
Glimepiride	Glimepiride	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Azithromycin	Azithromycin	21	20
Donepezil Hcl	Donepezil Hcl	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Torsemide	Torsemide	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Cefdinir	Cefdinir	17	16
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Baclofen	Baclofen	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Ketoconazole	Ketoconazole	16	15
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	14	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Estradiol	Estradiol	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Dofetilide	Dofetilide	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Valsartan	Valsartan	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Folic Acid	Folic Acid	11	suppressed
Niacin Er	Niacin	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error